Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is that all you have? Lot of effort on your part but not much return. Seems like you should have something substantial with all of the time you have invested in this stock. Seems like a lot of time wasted to me but.........
Good luck with whatever you are trying to do.
So let me get this straight. You are implying that these world renowned oncologists (Lohr, Hildago and Von Hoff ), who have devoted their lives to finding a cure for pancreatic cancer, have aligned themselves with a penny stock scam?????????
Please respond to this. I would Love to know your theory on why these devOted and probabLy extremely well to do oncologists would do this.
Does this mean that Pharmacyte may conduct a clinical trial? But I thought.........??
How about explaining this previous post from July frosr6?
Would really like to know about the cake walk that wasn't.
You were correct about one thing, the EMA has caught on!
On the subject of fake cancer cures and Pharmacyte:
There have been 2 human clinical trials that have produced better results than the current gold standard , so I would hardly call PMCB's treatment a fake cure. I mean after all, the FDA gave PMCB Orphan Drug Status based off of that cancer treatment.
Please explain how PMCB is using Stem Cells?
You obviously are doing a ton of research. I am interested in this subject.
Once again. Nothing to do with PMCB.
PMCB is NOT one of the 25 companies that the article is referring to as you are trying to make it seem.
By the way, the article that you are referencing is from 2007!
ROTFL!!!!!
How do explain this? Desperation seems to be kicking in!
http://globenewswire.com/news-release/2014/12/22/693421/10113176/en/FDA-Grants-Orphan-Drug-Designation-to-Nuvilex-for-Pancreatic-Cancer-Treatment.html
May. 15, 2015 7:39 AM ET | About: SPYR, Inc. (SPYR)
Disclosure: The author is short SPYR.The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.
Just curious Aly? Is there any scenario in which you would invest in this PMCB?
I understand why some of you are here at the Pharmacyte board. I would Probably bE Taking thE same approach but you may want to jump on the train before it leaves the station. All of the effort trying to prove that this is a pump and dump is falling on deaf ears. The theory of Dr Daniel Von Hoff, Dr Mathais Lohr, Ann Simpson etc...aligning themselves with a pump and dump is laughable. You may want to listen and pay attention to the information that some of the longs are providing here.
Time spent worrying about someone else is time taken away from yourself.
http://en.m.wikipedia.org/wiki/Cutting_off_the_nose_to_spite_the_face
This is getting a little scary for some that are invested in other coMpaNies. Keep Doing your speculating over here while Dr Von Hoff puts this pump and dump on the map. Oh, by the way, did you see that our world famous oncologist was voted researcher of the year? How in Mannkind can that happen?
https://www.tgen.org/home/news/2015-media-releases/tgens-dr-daniel-d-von-hoff-named-researcher-of-the-year.aspx#.VSwn_xg8KrU
This trumps everything written in your post. Remember these initials.......DVH.
https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=PMCB&pageno=&storyid=201502190930PRIMZONEFULLFEED10120960&provider=PRIMZONE&product=FULLFEED&
Dr Von Hoff designed the study but is not involved. That is laughable!
http://globenewswire.com/news-release/2015/02/19/708045/10120960/en/PharmaCyte-Biotech-Initiates-Expanded-Follow-up-Study-in-the-United-States-on-the-Accumulation-of-Malignant-Ascites-Fluid.html
This speaks volumes.......
That's like taking an IQ test designed by Albert Einstein but doesn't mean he's your personal tutor. (if he was alive if coarse).
Maybe the janitor at TD2 is doing the follow up study. I hear that he stayed at a Holiday Inn once!
http://globenewswire.com/news-release/2015/02/19/708045/10120960/en/PharmaCyte-Biotech-Initiates-Expanded-Follow-up-Study-in-the-United-States-on-the-Accumulation-of-Malignant-Ascites-Fluid.html
It's up to you to prove that he is not working with cell in a box.
http://www.td2inc.com/leadership/daniel-von-hoff
A little nervous about this guy?
http://en.m.wikipedia.org/wiki/Daniel_Von_Hoff
It's called distraction. Dr Von Hoff is going to introduce cell in a box to the world soon.
I wonder if Dr Von Hoff still has Christmas decorations up at TD2? I really don't care. What I do know is that in Dr Von Hoffs study, mice treated with cell in a box plus Ifosfomide lived significantly longer than mice that were not treated. I would imagine that the best pancreatic oncologist in the world will probably get better results the second go around with more groups of mice.
Common sense would suggest that if Dr Von Hoff obtained successful results on the initial pilot preclinical study, he will obtain successful results in his follow-up study! He is 3 weeks in to this follow-up study and should have results soon!
http://globenewswire.com/news-release/2014/11/19/684617/10108949/en/Nuvilex-Announces-Preliminary-Data-From-Preclinical-Study-of-Effects-of-Its-Pancreatic-Cancer-Treatment-on-Ascites-Fluid-Formation.html
No one can seem to answer this simple question.
Do you think that Daniel Von Hoff would associate himself with a Pump-n-Dump?
I didn't ask you if he was involved. Let me repeat my question.
Do you think that Daniel Von Hoff would associate himself with a Pump-n-Dump?
Do you think that Daniel Von Hoff would associate himself with a Pump-n-Dump?
This is what I hedged out of today's news.
This preclinical study will be conducted by Translational Drug Development (TD2) in the United States. Pancreatic cancer expert Dr. Daniel D. Von Hoff is the Chief Development Officer of TD2 and a principal architect of the study. It is expected that the study will begin in approximately two weeks.
So it's not the janitor or college interns at TD2 heading the preclinical studies as some here have suggested?
"Pancreatic cancer expert Dr. Daniel D. Von Hoff is the Chief Development Officer of TD2 and a principal architect of the study. It is expected that the study will begin in approximately two weeks."
Thanks for posting that Bull
Pete, could you be referring to this Dr Von Hoff?
http://www.standup2cancer.org/dream_teams/view/cutting_the_fuel_supply_a_new_approach_to_the_treatment_of_pancreatic_cance
Touché Otsy! You got me there. I will say that it's nice to see the nervousness and desperation though.
Dangerous for whom? The shorts?
0 for 2 today.
http://www.nuvilex.com/
No, Ken Waggoner vs nothing in that post. Please provide evidence as I asked in a previous post, that what you write is true.
I have posted evidence, now it is your turn.
VON HOFF DID CONTACT NUVILEX.
http://www.stockmarketmediagroup.com/wp-content/uploads/2014/06/NVLX-CEO-COO-Interview.mp3
10:30 into the interview.
Please provide a link indicating that what you say is true.